Home > PE Ratio > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of SUN PHARMACEUTICAL INDUSTRIES is 39.63.

Share Price ₹1,486.4Apr 24,2024
Market Cap ₹356,620.0 Cr
Earnings-TTM₹8,998.6 CrTTM-Consolidated Results
Price/Earnings39.63xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of SUN PHARMACEUTICAL INDUSTRIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SUN PHARMACEUTICAL INDUSTRIES is calculated as :

Current Market Cap [ ₹356,620.0 Cr] as on Apr 24,2024

(/) Earnings [ ₹8,998.6 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 39.63x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SUN PHARMACEUTICAL INDUSTRIES , the investors are currently willing to pay 39.63 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUN PHARMACEUTICAL INDUSTRIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SUN PHARMACEUTICAL INDUSTRIES over the last five years.

Historical PE (Price/Earnings) ratio chart of SUN PHARMACEUTICAL INDUSTRIES


PE Ratio Performance Analysis for SUN PHARMACEUTICAL INDUSTRIES

- SUN PHARMACEUTICAL INDUSTRIES 's latest p/e ratio is 39.63x.

- SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 41.97x.

- SUN PHARMACEUTICAL INDUSTRIES 's operated at median p/e ratio of 43.14x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio peaked in Mar2022 at 67.07x.

- SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio hit its five-year low in Mar2020 of 22.44x.


How does SUN PHARMACEUTICAL INDUSTRIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SUN PHARMACEUTICAL INDUSTRIES 8,998.6339.63356,620.0
CIPLA LTD3,744.0330.16112,938.0
DR REDDYS LABORATORIES LTD5,209.4019.0699,276.9
ZYDUS LIFESCIENCES LTD2,954.2031.7993,921.9
DIVIS LABORATORIES LTD1,382.9773.26101,315.0
MANKIND PHARMA LTD1,743.3055.1596,143.2
TORRENT PHARMACEUTICALS LTD1,494.0060.8390,872.6
LUPIN LTD1,809.7439.7972,010.8
AUROBINDO PHARMA LTD2,777.8922.8663,492.3
ABBOTT INDIA LTD1,145.5847.2354,105.4
ALKEM LABORATORIES LTD1,574.6635.7856,337.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SUN PHARMACEUTICAL INDUSTRIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.06x
Max industry PE 73.26x
Median industry PE 39.63x
Average industry PE 41.41x



You may also like the below Video Courses